Gross Profit - Samsung Biologics Co Ltd (KRX:207940) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 781 000 KRW

Updated:

Samsung Biologics Co Ltd
Gross Profit

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Samsung Biologics Co Ltd
Gross Profit Peer Comparison

P

087010

K

278650

S

237690

F

220100

L

141080

Company		Gross Profit	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Samsung Biologics Co Ltd KRX:207940	Gross Profit ₩1.8T	CAGR 3-Years 63%	CAGR 5-Years 66%	CAGR 10-Years N/A
P	Peptron Inc KOSDAQ:087010	Gross Profit ₩1.1B	CAGR 3-Years 0%	CAGR 5-Years -5%	CAGR 10-Years N/A
K	Knotus Co Ltd KOSDAQ:278650	Gross Profit ₩36.4B	CAGR 3-Years -5%	CAGR 5-Years 6%	CAGR 10-Years N/A
S	ST Pharm Co Ltd KOSDAQ:237690	Gross Profit ₩112.1B	CAGR 3-Years 78%	CAGR 5-Years 109%	CAGR 10-Years N/A
F	FutureChem Co Ltd KOSDAQ:220100	Gross Profit ₩1.6B	CAGR 3-Years -18%	CAGR 5-Years N/A	CAGR 10-Years N/A
L	LegoChem Biosciences Inc KOSDAQ:141080	Gross Profit ₩17.8B	CAGR 3-Years -21%	CAGR 5-Years 25%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Gross Profit amounts to 1.8T KRW.

Over the last year, the Gross Profit growth was 23%. The average annual Gross Profit growth rates for Samsung Biologics Co Ltd have been 63% over the past three years , 66% over the past five years .

Join more than 137,500+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.